Product
Modified early post-operative intraperitoneal chemotherapy (mEPIC)
1 clinical trial
3 indications
Indication
Peritoneal CarcinomatosisIndication
Appendiceal NeoplasmsIndication
Colorectal Cancer MetastaticClinical trial
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)Status: Not yet recruiting, Estimated PCD: 2026-01-01